Tag Archives: IDYA

Northland Securities Remains a Buy on IDEAYA Biosciences (IDYA)

Northland Securities analyst Tim Chiang reiterated a Buy rating on IDEAYA Biosciences (IDYA – Research Report) today and set a price target of $28.00. The company’s shares closed last Friday at $11.63. According to TipRanks.com, Chiang is a 1-star analyst

IDEAYA Biosciences (IDYA) Received its Third Buy in a Row

After Oppenheimer and H.C. Wainwright gave IDEAYA Biosciences (NASDAQ: IDYA) a Buy rating last month, the company received another Buy, this time from Northland Securities. Analyst Tim Chiang maintained a Buy rating on IDEAYA Biosciences today and set a price

IDEAYA Biosciences (IDYA) Gets a Buy Rating from Oppenheimer

The company’s shares closed last Tuesday at $11.84, close to its 52-week high of $11.87. According to TipRanks.com, DeGeeter is a 5-star analyst with an average return of 21.8% and a 50.3% success rate. DeGeeter covers the Healthcare sector, focusing

IDEAYA Biosciences (IDYA) Receives a Rating Update from a Top Analyst

H.C. Wainwright analyst Edward White maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report) today and set a price target of $13.00. The company’s shares closed last Friday at $8.04. According to TipRanks.com, White is a top 100

IDEAYA Biosciences (IDYA) Receives a Buy from Oppenheimer

In a report released yesterday, Kevin DeGeeter from Oppenheimer maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report), with a price target of $17.00. The company’s shares closed last Friday at $7.82. According to TipRanks.com, DeGeeter is a